Roth MKM analyst Matt Koranda raised the firm’s price target on Lovesac to $31 from $30 and keeps a Buy rating on the shares after its Q2 results and reduced guidance. The company delivered “healthy enough” results in a largely transitional Q2 despite a challenging macro backdrop, while its “better-than-feared” FY25 guidance also supported the post-earnings stock rally, the analyst tells investors in a research note. The firm further sees “several positives” for Lovesac, including new product growth, a potential uptick in housing turnover, and operating expense leverage following a sustained period of re-investment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LOVE:
- Lovesac price target raised to $35 from $30 at Craig-Hallum
- Lovesac commentary suggests faster pace of product innovation, says Maxim
- Morning Movers: Signet Jewelers surges following second quarter results
- Lovesac sees FY25 EPS $1.01-$1.26, consensus $1.23
- Lovesac reports Q2 EPS (38c), consensus (44c)